The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Burlingame Robert since 2009.
The trader's CIK number is 1383295.
At the time of the last reporting, Burlingame Robert was the Director of Sonoma Pharmaceuticals, Inc.. (stock ticker symbol SNOA).
Also see all insider trading activities at Sonoma Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | OCLS | 788,035 | $922,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-06-01 | OCLS | Buy | 569,801 | 1.17 | 666,667 |
| 2009-03-04 | OCLS | Buy | 218,234 | 1.17 | 255,333 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burlingame Robert (Director of Sonoma Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.